AI Verdict
INVUP has stronger fundamentals based on our AI analysis.
IOBT vs INVUP Fundamental Comparison
| Metric | IOBT | INVUP |
|---|---|---|
| Revenue | N/A | $29.1M |
| Net Income | $-57.0M | $-1.1M |
| Net Margin | N/A | -3.8% |
| ROE | -6,258.6% | -6.7% |
| ROA | -142.7% | -4.1% |
| Current Ratio | 2.01x | 2.44x |
| Debt/Equity | 18.29x | 0.01x |
| EPS | $-0.86 | $0.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IOBT vs INVUP: Frequently Asked Questions
Is IOBT or INVUP a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), INVUP has stronger fundamentals. IOBT is rated STRONG SELL (95% confidence) while INVUP is rated SELL (78% confidence). This is not investment advice.
How does IOBT compare to INVUP fundamentally?
IO Biotech, Inc. has ROE of -6,258.6% vs Investview, Inc.'s -6.7%. Net margins are N/A vs -3.8% respectively.
Which stock pays higher dividends, IOBT or INVUP?
IOBT has a dividend yield of N/A or no dividend while INVUP has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IOBT or INVUP for long term?
For long-term investing, consider that IOBT has STRONG SELL rating with 95% confidence, while INVUP has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IOBT vs INVUP?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IOBT vs INVUP, the AI consensus favors INVUP based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.